ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Metabolism and Pharmacokinetics (DMPK) Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-38O16612
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Drug Metabolism and Pharmacokinetics DMPK Market Research Report 2024
BUY CHAPTERS

Global Drug Metabolism and Pharmacokinetics (DMPK) Market Research Report 2024

Code: QYRE-Auto-38O16612
Report
April 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurofins Discovery
Inotiv, Inc.
Evotec AG
Sai Life Sciences
Sygnature Discovery
WuXi AppTec
Q2 Solutions
Jubilant Biosys
Frontage Laboratories
Invitrocue
Creative-Biolabs
Agilent
H3D，Inc.
LabCorp
Bioduro-Sundia
Allucent
Hangzhou Tigermed Consulting Co
CrownBioscience

Drug Metabolism and Pharmacokinetics (DMPK) Market

DMPK is an acronym that stands for drug metabolism and pharmacokinetics. This is a discipline that helps to identify drugs that are likely to be suitable for advancement through the drug development process. It considers how the drug is metabolized and processed by the body.
The global Drug Metabolism and Pharmacokinetics (DMPK) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Drug Metabolism and Pharmacokinetics (DMPK) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Drug Metabolism and Pharmacokinetics (DMPK) in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Drug Metabolism and Pharmacokinetics (DMPK) include Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, WuXi AppTec, Hangzhou Tigermed Consulting Co, Q2 Solutions, Jubilant Biosys, Frontage Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Drug Metabolism and Pharmacokinetics (DMPK), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Metabolism and Pharmacokinetics (DMPK).
The Drug Metabolism and Pharmacokinetics (DMPK) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Metabolism and Pharmacokinetics (DMPK) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Metabolism and Pharmacokinetics (DMPK) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Drug Metabolism and Pharmacokinetics (DMPK) Market Report

Report Metric Details
Report Name Drug Metabolism and Pharmacokinetics (DMPK) Market
Segment by Type
  • Small Molecules
  • Biologics
Segment by Application
  • Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, WuXi AppTec, Hangzhou Tigermed Consulting Co, Q2 Solutions, Jubilant Biosys, Frontage Laboratories, Invitrocue, Creative Biolabs, CrownBioscience, Agilent, H3D, LABCORP, Bioduro-Sundia, Allucent
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Drug Metabolism and Pharmacokinetics (DMPK) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Metabolism and Pharmacokinetics (DMPK) Market report?

Ans: The main players in the Drug Metabolism and Pharmacokinetics (DMPK) Market are Eurofins Discovery, Inotiv, Evotec, Sai Life Sciences, Sygnature Discovery, WuXi AppTec, Hangzhou Tigermed Consulting Co, Q2 Solutions, Jubilant Biosys, Frontage Laboratories, Invitrocue, Creative Biolabs, CrownBioscience, Agilent, H3D, LABCORP, Bioduro-Sundia, Allucent

What are the Application segmentation covered in the Drug Metabolism and Pharmacokinetics (DMPK) Market report?

Ans: The Applications covered in the Drug Metabolism and Pharmacokinetics (DMPK) Market report are Biopharmaceutical Companies, Government and Academic Institutes, Others

What are the Type segmentation covered in the Drug Metabolism and Pharmacokinetics (DMPK) Market report?

Ans: The Types covered in the Drug Metabolism and Pharmacokinetics (DMPK) Market report are Small Molecules, Biologics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Perspective (2019-2030)
2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Growth Trends by Region
2.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Metabolism and Pharmacokinetics (DMPK) Historic Market Size by Region (2019-2024)
2.2.3 Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Region (2025-2030)
2.3 Drug Metabolism and Pharmacokinetics (DMPK) Market Dynamics
2.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Industry Trends
2.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
2.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Market Challenges
2.3.4 Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Revenue
3.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Revenue (2019-2024)
3.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Players (2019-2024)
3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Metabolism and Pharmacokinetics (DMPK) Revenue
3.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Concentration Ratio
3.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Metabolism and Pharmacokinetics (DMPK) Revenue in 2023
3.5 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Head office and Area Served
3.6 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Product and Application
3.7 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Metabolism and Pharmacokinetics (DMPK) Breakdown Data by Type
4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Historic Market Size by Type (2019-2024)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Type (2025-2030)
5 Drug Metabolism and Pharmacokinetics (DMPK) Breakdown Data by Application
5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Historic Market Size by Application (2019-2024)
5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
6.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
6.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
7.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
8.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
9.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
9.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
10.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.1.4 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.1.5 Eurofins Discovery Recent Development
11.2 Inotiv
11.2.1 Inotiv Company Details
11.2.2 Inotiv Business Overview
11.2.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.2.4 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.2.5 Inotiv Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.3.4 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.3.5 Evotec Recent Development
11.4 Sai Life Sciences
11.4.1 Sai Life Sciences Company Details
11.4.2 Sai Life Sciences Business Overview
11.4.3 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.4.4 Sai Life Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.4.5 Sai Life Sciences Recent Development
11.5 Sygnature Discovery
11.5.1 Sygnature Discovery Company Details
11.5.2 Sygnature Discovery Business Overview
11.5.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.5.4 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.5.5 Sygnature Discovery Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.6.4 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.6.5 WuXi AppTec Recent Development
11.7 Hangzhou Tigermed Consulting Co
11.7.1 Hangzhou Tigermed Consulting Co Company Details
11.7.2 Hangzhou Tigermed Consulting Co Business Overview
11.7.3 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.7.4 Hangzhou Tigermed Consulting Co Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.7.5 Hangzhou Tigermed Consulting Co Recent Development
11.8 Q2 Solutions
11.8.1 Q2 Solutions Company Details
11.8.2 Q2 Solutions Business Overview
11.8.3 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.8.4 Q2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.8.5 Q2 Solutions Recent Development
11.9 Jubilant Biosys
11.9.1 Jubilant Biosys Company Details
11.9.2 Jubilant Biosys Business Overview
11.9.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.9.4 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.9.5 Jubilant Biosys Recent Development
11.10 Frontage Laboratories
11.10.1 Frontage Laboratories Company Details
11.10.2 Frontage Laboratories Business Overview
11.10.3 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.10.4 Frontage Laboratories Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.10.5 Frontage Laboratories Recent Development
11.11 Invitrocue
11.11.1 Invitrocue Company Details
11.11.2 Invitrocue Business Overview
11.11.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.11.4 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.11.5 Invitrocue Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.12.4 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 CrownBioscience
11.13.1 CrownBioscience Company Details
11.13.2 CrownBioscience Business Overview
11.13.3 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.13.4 CrownBioscience Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.13.5 CrownBioscience Recent Development
11.14 Agilent
11.14.1 Agilent Company Details
11.14.2 Agilent Business Overview
11.14.3 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.14.4 Agilent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.14.5 Agilent Recent Development
11.15 H3D
11.15.1 H3D Company Details
11.15.2 H3D Business Overview
11.15.3 H3D Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.15.4 H3D Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.15.5 H3D Recent Development
11.16 LABCORP
11.16.1 LABCORP Company Details
11.16.2 LABCORP Business Overview
11.16.3 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.16.4 LABCORP Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.16.5 LABCORP Recent Development
11.17 Bioduro-Sundia
11.17.1 Bioduro-Sundia Company Details
11.17.2 Bioduro-Sundia Business Overview
11.17.3 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.17.4 Bioduro-Sundia Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.17.5 Bioduro-Sundia Recent Development
11.18 Allucent
11.18.1 Allucent Company Details
11.18.2 Allucent Business Overview
11.18.3 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.18.4 Allucent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.18.5 Allucent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eurofins Discovery
Inotiv, Inc.
Evotec AG
Sai Life Sciences
Sygnature Discovery
WuXi AppTec
Q2 Solutions
Jubilant Biosys
Frontage Laboratories
Invitrocue
Creative-Biolabs
Agilent
H3D，Inc.
LabCorp
Bioduro-Sundia
Allucent
Hangzhou Tigermed Consulting Co
CrownBioscience
List of Tables
 Table 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Small Molecules
 Table 3. Key Players of Biologics
 Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region (2019-2024)
 Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region (2025-2030)
 Table 10. Drug Metabolism and Pharmacokinetics (DMPK) Market Trends
 Table 11. Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
 Table 12. Drug Metabolism and Pharmacokinetics (DMPK) Market Challenges
 Table 13. Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints
 Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Players (2019-2024)
 Table 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) as of 2023)
 Table 17. Ranking of Global Top Drug Metabolism and Pharmacokinetics (DMPK) Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Headquarters and Area Served
 Table 20. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Product and Application
 Table 21. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Type (2019-2024)
 Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Type (2025-2030)
 Table 27. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Application (2019-2024)
 Table 29. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Application (2025-2030)
 Table 31. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Eurofins Discovery Company Details
 Table 47. Eurofins Discovery Business Overview
 Table 48. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 49. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 50. Eurofins Discovery Recent Development
 Table 51. Inotiv Company Details
 Table 52. Inotiv Business Overview
 Table 53. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 54. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 55. Inotiv Recent Development
 Table 56. Evotec Company Details
 Table 57. Evotec Business Overview
 Table 58. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 59. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 60. Evotec Recent Development
 Table 61. Sai Life Sciences Company Details
 Table 62. Sai Life Sciences Business Overview
 Table 63. Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 64. Sai Life Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 65. Sai Life Sciences Recent Development
 Table 66. Sygnature Discovery Company Details
 Table 67. Sygnature Discovery Business Overview
 Table 68. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 69. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 70. Sygnature Discovery Recent Development
 Table 71. WuXi AppTec Company Details
 Table 72. WuXi AppTec Business Overview
 Table 73. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 74. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 75. WuXi AppTec Recent Development
 Table 76. Hangzhou Tigermed Consulting Co Company Details
 Table 77. Hangzhou Tigermed Consulting Co Business Overview
 Table 78. Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 79. Hangzhou Tigermed Consulting Co Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 80. Hangzhou Tigermed Consulting Co Recent Development
 Table 81. Q2 Solutions Company Details
 Table 82. Q2 Solutions Business Overview
 Table 83. Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 84. Q2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 85. Q2 Solutions Recent Development
 Table 86. Jubilant Biosys Company Details
 Table 87. Jubilant Biosys Business Overview
 Table 88. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 89. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 90. Jubilant Biosys Recent Development
 Table 91. Frontage Laboratories Company Details
 Table 92. Frontage Laboratories Business Overview
 Table 93. Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 94. Frontage Laboratories Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 95. Frontage Laboratories Recent Development
 Table 96. Invitrocue Company Details
 Table 97. Invitrocue Business Overview
 Table 98. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 99. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 100. Invitrocue Recent Development
 Table 101. Creative Biolabs Company Details
 Table 102. Creative Biolabs Business Overview
 Table 103. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 104. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 105. Creative Biolabs Recent Development
 Table 106. CrownBioscience Company Details
 Table 107. CrownBioscience Business Overview
 Table 108. CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 109. CrownBioscience Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 110. CrownBioscience Recent Development
 Table 111. Agilent Company Details
 Table 112. Agilent Business Overview
 Table 113. Agilent Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 114. Agilent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 115. Agilent Recent Development
 Table 116. H3D Company Details
 Table 117. H3D Business Overview
 Table 118. H3D Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 119. H3D Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 120. H3D Recent Development
 Table 121. LABCORP Company Details
 Table 122. LABCORP Business Overview
 Table 123. LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 124. LABCORP Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 125. LABCORP Recent Development
 Table 126. Bioduro-Sundia Company Details
 Table 127. Bioduro-Sundia Business Overview
 Table 128. Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 129. Bioduro-Sundia Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 130. Bioduro-Sundia Recent Development
 Table 131. Allucent Company Details
 Table 132. Allucent Business Overview
 Table 133. Allucent Drug Metabolism and Pharmacokinetics (DMPK) Product
 Table 134. Allucent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
 Table 135. Allucent Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Picture
 Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type: 2023 VS 2030
 Figure 4. Small Molecules Features
 Figure 5. Biologics Features
 Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application: 2023 VS 2030
 Figure 8. Biopharmaceutical Companies Case Studies
 Figure 9. Government and Academic Institutes Case Studies
 Figure 10. Others Case Studies
 Figure 11. Drug Metabolism and Pharmacokinetics (DMPK) Report Years Considered
 Figure 12. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region: 2023 VS 2030
 Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Players in 2023
 Figure 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Revenue in 2023
 Figure 18. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
 Figure 20. United States Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
 Figure 24. Germany Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region (2019-2030)
 Figure 32. China Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
 Figure 40. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
 Figure 44. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 48. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 49. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 50. Sai Life Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 51. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 52. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 53. Hangzhou Tigermed Consulting Co Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 54. Q2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 55. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 56. Frontage Laboratories Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 57. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 58. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 59. CrownBioscience Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 60. Agilent Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 61. H3D Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 62. LABCORP Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 63. Bioduro-Sundia Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 64. Allucent Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global DMPK Service Market Research Report 2024
Global ADME DMPK Studies Market Research Report 2024
Global Preclinical DMPK Studies Market Research Report 2024
Global Drug Metabolism and Pharmacokinetics DMPK Service Market Research Report 2024
Global PK PD Modeling Market Research Report 2024
Global Pharmacokinetic Service Market Research Report 2025
In Vivo and In Vitro DMPK and ADME Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolism Drugs Market Research Report 2025
Global Pharmacokinetic Research Market Research Report 2024
Drugs for Metabolic Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metabolic Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmacokinetics Testing Service Market Research Report 2024
Global Metabolism Detection Kit Market Research Report 2024
Global Metabolism Assay Kit Market Research Report 2024
Global Metabolomics Kit Market Research Report 2024
Global Pharmacokinetics Software Market Research Report 2024
Global Pharmacokinetic Research Service Market Research Report 2024
Deuterium substituteddrugs Market
Metabolic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Management System Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions